Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of surgery in persons with hemophilia A receiving emicizumab prophylaxis: data from a national hemophilia treatment center.
Cohen O, Levy-Mendelovich S, Budnik I, Ludan N, Lyskov SK, Livnat T, Avishai E, Efros O, Lubetsky A, Lalezari S, Misgav M, Brutman-Barazani T, Kenet G, Barg AA. Cohen O, et al. Among authors: lubetsky a. Res Pract Thromb Haemost. 2023 Aug 23;7(6):102178. doi: 10.1016/j.rpth.2023.102178. eCollection 2023 Aug. Res Pract Thromb Haemost. 2023. PMID: 37876894 Free PMC article.
Paediatric cerebral sinus vein thrombosis. A multi-center, case-controlled study.
Kenet G, Waldman D, Lubetsky A, Kornbrut N, Khalil A, Koren A, Wolach B, Fattal A, Kapelushnik J, Tamary H, Yacobovitch J, Raveh E, Revel-Vilk S, Toren A, Brenner B. Kenet G, et al. Among authors: lubetsky a. Thromb Haemost. 2004 Oct;92(4):713-8. doi: 10.1160/TH04-03-0182. Thromb Haemost. 2004. PMID: 15467900
The in-vitro effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor on clot formation and susceptibility to tissue plasminogen activator-induced fibrinolysis in hemodilution model.
Shenkman B, Livnat T, Lubetsky A, Tamarin I, Budnik I, Einav Y, Martinowitz U. Shenkman B, et al. Among authors: lubetsky a. Blood Coagul Fibrinolysis. 2012 Jul;23(5):370-8. doi: 10.1097/MBC.0b013e328352cb3f. Blood Coagul Fibrinolysis. 2012. PMID: 22498982
The potential role of emicizumab prophylaxis in severe von Willebrand disease.
Barg AA, Avishai E, Budnik I, Brutman TB, Tamarin I, Dardik R, Bashari D, Misgav M, Lubetsky A, Lalezari S, Livnat T, Kenet G. Barg AA, et al. Among authors: lubetsky a. Blood Cells Mol Dis. 2021 Mar;87:102530. doi: 10.1016/j.bcmd.2020.102530. Epub 2020 Dec 8. Blood Cells Mol Dis. 2021. PMID: 33341070
112 results